Mentor Launches New Self-Cath(R) Hydrogel(TM) Intermittent Catheter.

SANTA BARBARA, Calif. -- Mentor Corporation (NYSE:MNT), a leading supplier of medical products in the United States and internationally, announced that it has launched its new Self-Cath(R) Hydrogel(TM) intermittent urinary catheter for the management of bladder control and urinary retention. The Self-Cath Hydrogel was launched in the United States, with launches in international markets planned later in the month.

"The unique features of the Self-Cath Hydrogel will positively impact patients who require intermittent catheterization to manage their bladder. Mentor clearly had the needs of the end-user in mind when creating this product," commented Evelyn M. Kliever, MA, RN, CRRN-A, CURN, Clinical Nurse Manager of Miller-Dwan Regional Rehabilitation Center.

The Self-Cath Hydrogel features a proprietary micro-bead lubricant coating that reduces urethral friction, while the introducer tip is designed to reduce the risk of urinary tract infections. The hybrid design of the catheter, combined with the additional benefits of contact free catheter usage and an innovative telescoping extension sleeve, are intended to provide additional protection against cross contamination of the catheter, which can lead to infection. The compact pocket-sized packaging presents a significant improvement over conventional catheters in maintaining privacy and ease of use.

"Understanding the clinical needs of individuals that catheterize, combined with our ability to identify next generation lubricant and process technologies, continues to position Mentor as a leading developer of urinary catheters," commented Joshua H. Levine, President and Chief Executive Officer of Mentor Corporation. "Our continuing commitment to develop market-driven products with the customer as our first priority is evident through the introduction of the Self-Cath Hydrogel."

Intermittent urinary catheterization has been identified as being the preferred method of bladder management as it most closely mimics the body's natural function. Engineering a reduction in the risk of urinary tract infections often associated with catheterization is an important advancement maintaining good health.

About Mentor Corporation

Founded in 1969, Mentor Corporation is a leading supplier of medical products for the global healthcare market. The Company develops, manufactures and markets innovative, science-based products for the aesthetics, urologic specialties and clinical and consumer healthcare markets around the world. The Company's website is www.mentorcorp.com.

Safe Harbor Statement

All statements included or incorporated by reference in this release, other than statements or characterizations of historical fact, are forward-looking statements. These forward-looking statements are based on our current expectations, estimates and projections about our industry, management's beliefs and certain assumptions made by us. Forward-looking statements can often be identified by words or phrases such as "anticipates," "scheduled," "expects," "intends," "plans," "predicts," "believes," "seeks," "estimates," "encouraged," "positive sign," "is confident," "may," "will," "should," "would," "would likely," "could," "potential," "in the future," "continue," similar expressions, and variations or negatives of these words. In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. These forward-looking statements speak only as of the date hereof and are based upon the information available to us at this time. Such information is subject to change, and we will not necessarily inform you of such changes. These statements are not guarantees of future results and are subject to risks, uncertainties and assumptions that are difficult to predict. Therefore, our actual results could differ materially and adversely from those expressed in any forward-looking statement as a result of various factors.

The Securities and Exchange Commission filings of Mentor, including, without limitation, its Annual Reports on Form 10-K, subsequent quarterly reports on Form 10-Q, and recent Current Reports on Form 8-K, discuss important risk factors that could contribute to such differences or otherwise affect its business, results of operations and financial condition. Mentor undertakes no obligation to revise or update publicly any forward-looking statement for any reason.